Sign in

    Kaitlyn Korich • Jefferies

    Kaitlyn Korich is an Equity Research Vice President at Jefferies, bringing specialized expertise in financial sector analysis. She currently covers a range of companies within the finance and investment banking industries, leveraging detailed research to inform institutional investment decisions, though specific company names and quantitative performance metrics are not publicly available. Korich began her career as an Analyst at Credit Suisse Securities (USA) LLC before moving to Jefferies in 2023, and she holds an undergraduate degree from Northeastern University. Her professional profile is bolstered by a robust background in equity research and a record of advancing through notable investment banks, though details on securities licenses or FINRA registration have not been explicitly confirmed.

    Kaitlyn Korich's questions to Biote Corp (BTMD) leadership

    Kaitlyn Korich's questions to Biote Corp (BTMD) leadership • Q2 2025

    Question

    Kaitlyn Korich from Jefferies sought to understand the biggest factors contributing to the variance between actual new clinic additions and prior expectations, which led to the revised guidance. She also asked if there have been any notable changes in the competitive landscape or broader consumer behavior.

    Answer

    CEO Bret Christensen explained that the guidance was revised downward after analyzing scenarios based on persistent headwinds, including a slowdown in new clinic starts, lower procedure volumes at existing clinics, and an uptick in attrition. He reiterated that the company's initiatives are focused on driving top-line growth by enhancing the value proposition for practitioners, which should improve both new clinic acquisition and retention over time, but these efforts require patience.

    Ask Fintool Equity Research AI